Annual accounts receivable:
$41.72M+$20.46M(+96.20%)Summary
- As of today (June 2, 2025), KNSA annual accounts receivable is $41.72 million, with the most recent change of +$20.46 million (+96.20%) on December 31, 2024.
- During the last 3 years, KNSA annual accounts receivable has risen by +$37.74 million (+947.03%).
- KNSA annual accounts receivable is now at all-time high.
Performance
KNSA Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$40.06M-$1.66M(-3.98%)Summary
- As of today (June 2, 2025), KNSA quarterly accounts receivable is $40.06 million, with the most recent change of -$1.66 million (-3.98%) on March 31, 2025.
- Over the past year, KNSA quarterly accounts receivable has increased by +$24.07 million (+150.48%).
- KNSA quarterly accounts receivable is now -3.98% below its all-time high of $41.72 million, reached on December 31, 2024.
Performance
KNSA Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
KNSA Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.2% | +150.5% |
| 3 y3 years | +947.0% | +36.1% |
| 5 y5 years | - | - |
KNSA Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +947.0% | -4.0% | +1217.5% |
| 5 y | 5-year | at high | >+9999.0% | -4.0% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -4.0% | >+9999.0% |
KNSA Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $40.06M(-4.0%) |
| Dec 2024 | $41.72M(+96.2%) | $41.72M(+67.6%) |
| Sep 2024 | - | $24.89M(+21.7%) |
| Jun 2024 | - | $20.45M(+27.9%) |
| Mar 2024 | - | $15.99M(-24.8%) |
| Dec 2023 | $21.27M | $21.27M(+599.3%) |
| Sep 2023 | - | $3.04M(-87.7%) |
| Jun 2023 | - | $24.65M(+232.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $7.42M(-41.4%) |
| Dec 2022 | $12.66M(+217.7%) | $12.66M(+13.5%) |
| Sep 2022 | - | $11.16M(+42.9%) |
| Jun 2022 | - | $7.81M(-73.5%) |
| Mar 2022 | - | $29.44M(+638.8%) |
| Dec 2021 | $3.98M(>+9900.0%) | $3.98M(+23.6%) |
| Sep 2021 | - | $3.22M(+26.4%) |
| Jun 2021 | - | $2.55M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Kiniksa Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual accounts receivable year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Kiniksa Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of KNSA is $41.72M
What is the all time high annual accounts receivable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual accounts receivable is $41.72M
What is Kiniksa Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, KNSA annual accounts receivable has changed by +$20.46M (+96.20%)
What is Kiniksa Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of KNSA is $40.06M
What is the all time high quarterly accounts receivable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly accounts receivable is $41.72M
What is Kiniksa Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, KNSA quarterly accounts receivable has changed by +$24.07M (+150.48%)